CRO/SPONSOR : The Nuances of Medical Device Trials A Triggered Approach to Site Monitoring INFORMATION TECHNOLOGY : Automating the Phase I Trial Also in this issue : FDA Addresses Concerns Over Foreign Studies, The Cost Factor in EU Drug Authorization, Baseball?s Ties to Comparative Effectiveness Research, Key Updates to the Form FDA 1572
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.